CAMP
CAMP4 Therapeutics CorporationNASDAQHealthcare$4.47+0.22%ClosedMarket Cap: $94.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
4.89
P/S
27.26
EV/EBITDA
0.23
DCF Value
$3.00
FCF Yield
-31.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
77.5%
Operating Margin
-1488.3%
Net Margin
-2298.5%
ROE
-162.5%
ROA
-68.2%
ROIC
-50.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $348.0K | -6.9% | $-12.8M | $-40.3M | $-0.78 | — |
| FY 2025 | $3.5M | 53.1% | $-52.1M | $-80.4M | $-2.65 | — |
| Q3 2025 | $795.0K | 47.7% | $-13.2M | $-15.1M | $-0.55 | — |
| Q2 2025 | $1.5M | 100.0% | $-13.0M | $-12.6M | $-0.62 | — |
| Q1 2025 | $858.0K | 100.0% | $-13.1M | $-12.4M | $-0.64 | — |
| Q4 2024 | $652.0K | 100.0% | $-14.0M | $-13.3M | $-0.68 | — |
| FY 2024 | $652.0K | 100.0% | $-53.1M | $-51.8M | $-2.66 | — |
| Q3 2024 | $0.00 | NaN% | $-13.5M | $-13.5M | $-0.69 | — |
| Q2 2024 | $0.00 | NaN% | $-12.7M | $-12.6M | $-0.80 | — |
| Q1 2024 | $0.00 | NaN% | $-12.9M | $-12.5M | $-1.03 | — |
| Q4 2023 | $0.00 | NaN% | $-13.5M | $-13.0M | $-2.27 | — |
| FY 2023 | $350.0K | 100.0% | $-51.9M | $-49.3M | $-4.07 | — |